Results 1-5 of 5 for narcolepsy speaker:Finian McGrath

Written Answers — Department of Health: Health Services Funding (13 Dec 2018)

Finian McGrath: ...by the HSE to commence development of peri- and post-operative services to support patients receiving Deep Brain Stimulation. Also, additional funding has been allocated to further develop the national narcolepsy services, in particular the transition of adolescents from Children's University Hospital to St. James's Hospital. Other improvements across neurology services include the...

Topical Issue Debate: Narcolepsy Issues (13 Dec 2016)

Finian McGrath: ...the Minister for Health, the Health Service Executive and GlaxoSmithKline Biological have been initiated by 51 individuals. The plaintiffs allege personal injury and claim the development of narcolepsy resulted from the administration of the H1N1 pandemic vaccine. Legal advice obtained by the Department recommended delegation of the management of these cases and any subsequent similar...

Topical Issue Debate: Narcolepsy Issues (13 Dec 2016)

Finian McGrath: I thank Deputy Michael D'Arcy for raising this very important issue and for allowing me the opportunity to give an update to the House on the matter. I acknowledge the impact of narcolepsy on all people who have been diagnosed with it. In particular, I am aware of a specific group of individuals who claim to have developed narcolepsy as a result of receiving pandemic vaccine during the 2009...

Written Answers — Department of Health: Vaccination Programme (4 Dec 2012)

Finian McGrath: To ask the Minister for Health his views on correspondence (details supplied) regarding narcolepsy. [53854/12]

Written Answers — Department of Health: Vaccination Programme (22 Nov 2012)

Finian McGrath: To ask the Minister for Health the position regarding the case of a person (details supplied) in Dublin 3 who contracted narcolepsy with cathaplexy from the Health Service Executive swine flu injection; the supports that will be put in place for them in the future; if they are entitled to compensation as a result of HSE administering the drug that caused it [52002/12]